Clinical Trial Update: Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of combining Sintilimab with chemotherapy and cryoablation in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• Sintilimab (sintilimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-Small-Cell Lung Cancer | Phase 4 | Status: NOT_YET_RECRUITING